Clinical Trials Browser

Phase 2 × Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer) × Clear all

NCT02459119 2020-08-06

Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)

Phase 2 Completed

17 enrolled 11 charts

Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)